The Accelerated Access Review (AAR) was commissioned by the government in November 2014. The final report makes recommendations to make it easier for NHS patients to access innovative medicines, medical technologies, diagnostics and digital products, improving efficiency and patient outcomes.
The AAR has been led by an independent chair, Sir Hugh Taylor, supported by Sir John Bell as Chair of the External Advisory Group. There has been extensive engagement with industry, the NHS, patients, academia and clinicians during its development.
As part of the review National Voices – a coalition of health and care charities – developed a series of ‘I Statements’ from the patient and service user’s perspective, which set out how people should be engaged at every stage of the innovation pathway.